• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EUS EXERA ULTRASONIC GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EUS EXERA ULTRASONIC GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT160-OL5
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Hemorrhage/Bleeding (1888); Pancreatitis (4481)
Event Date 12/28/2021
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: retrospective study in two tertiary centers." patients and methods: a bicentric retrospective study was performed that included patients with histologically confirmed nf pnets who were consecutively treated by eus-rfa.Results: in 27 patients, eusrfa was successfully performed.All patients had sporadic g1 lesions.Overall, 9/ 27 lesions were cystic.The mean hospital stay was 3.2 days.Complete treatment response was confirmed in 25/27patients on cross-sectional imaging.Two patients had two eus-rfa sessions until complete necrosis was observed.Periprocedural acute pancreatitis occurred in 4/27 , three of them were treated by endoscopic cystogastrostomy.One patient underwent secondary surgery.The histopathology of the resected specimen revealed 3 mm of residual tumor tissue.Type of adverse events/number of patients.Mild postprocedural abdominal pain -3.Acute pancreatitis -1.Periprocedural bleeding -2 (slight or minor).Acute pancreatitis -3 (table 3).This literature article requires 4 reports.The related patient identifiers are as follows: (b)(6) as patient 1 for acute pancreatitis.(b)(6) as patient 2 for acute pancreatitis.(b)(6) as patient 3 for acute pancreatitis.(b)(6) for postprocedural abdominal pain, acute pancreatitis, and periprocedural bleeding.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes corrections to e4 and g2 to provide information that was inadvertently not included on the initial medwatch.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUS EXERA ULTRASONIC GASTROVIDEOSCOPE
Type of Device
ULTRASONIC GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer Contact
masaharu hirose
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8-061
JA   961-8061
426422891
MDR Report Key15674618
MDR Text Key302431348
Report Number3002808148-2022-03555
Device Sequence Number1
Product Code ODG
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT160-OL5
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNKNOWN, EUSRA RF ELECTRODE
Patient Outcome(s) Other; Required Intervention;
Patient SexPrefer Not To Disclose
-
-